The MYC amplified cases did not have a higher mutation burden or association with other hallmark mutations of PDA; however, amplification was significantly over-represented in the adenosquamous subtype of pancreatic carcinoma (Supplementary Fig. 14). Here, MYC is linked to exocrine pancreatic carcinoma.